Daniel Calkins

Companies

• Verastem OncologyChief financial officer Oct 26, 2023 to now¹
• Verastem OncologyVice President of Finance Nov 8, 2022 to Oct 10, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Verastem Oncology VSTM118,014 shares³$1.0M at $8.77Sep 21, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 21, 2026Sold 55 shares at $7.70 of Verastem Oncology³
• Jun 22, 2026Sold 57 shares at $4.13 of Verastem Oncology⁴
• Jun 22, 2026Sold 4,032 shares at $4.18 of Verastem Oncology⁴
• Mar 20, 2026Granted 57 shares at $5.74 of Verastem Oncology⁵
• Jan 21, 2026Granted 16,665 shares of Verastem Oncology⁶
• Jan 12, 2026Sold 5,039 shares at $7.16 of Verastem Oncology⁷
• Dec 24, 2025Sold 80 shares at $7.86 of Verastem Oncology⁸
• Sep 24, 2025Sold 25 shares at $9.23 of Verastem Oncology⁹
• Sep 22, 2025Sold 57 shares at $9.08 of Verastem Oncology⁹
• Jun 23, 2025Sold 25 shares at $4.71 of Verastem Oncology¹⁰
• Jun 20, 2025Sold 4,110 shares at $5.13 of Verastem Oncology¹⁰
• May 20, 2025Sold 11,143 shares at $8.13 of Verastem Oncology¹¹
• May 16, 2025Granted 38,850 shares of Verastem Oncology¹¹
• Mar 24, 2025Sold 26 shares at $7.04 of Verastem Oncology¹²
• Mar 20, 2025Sold 65 shares at $6.89 of Verastem Oncology¹²
• Jan 10, 2025Granted 38,800 shares of Verastem Oncology¹³
• Jan 6, 2025Sold 6 shares at $6.94 of Verastem Oncology¹⁴
• Dec 24, 2024Sold 28 shares at $3.91 of Verastem Oncology¹⁵
• Dec 20, 2024Sold 65 shares at $4.34 of Verastem Oncology¹⁵
• Oct 7, 2024Sold 6 shares at $2.86 of Verastem Oncology¹⁶
• Sep 24, 2024Sold 28 shares at $2.68 of Verastem Oncology¹⁷
• Sep 20, 2024Sold 65 shares at $2.80 of Verastem Oncology¹⁷
• Jul 9, 2024Sold 7 shares at $2.62 of Verastem Oncology¹⁸
• Jun 24, 2024Sold 28 shares at $3.15 of Verastem Oncology¹⁹
• Jun 20, 2024Sold 67 shares at $3.16 of Verastem Oncology²⁰